Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis.

Yu S, Chu Y, Li G, Ren L, Zhang Q, Wu L.

J Am Heart Assoc. 2017 Mar 20;6(3). pii: e004180. doi: 10.1161/JAHA.116.004180. Review.

2.

A Practical Approach to Gastrointestinal Complications of Diabetes.

Maisey A.

Diabetes Ther. 2016 Sep;7(3):379-86. doi: 10.1007/s13300-016-0182-y. Epub 2016 Jul 18. Review.

3.

Consequences of bile salt biotransformations by intestinal bacteria.

Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB.

Gut Microbes. 2016;7(1):22-39. doi: 10.1080/19490976.2015.1127483. Review.

4.

Effect of a Probiotic Preparation (VSL#3) on CardiovascularRisk Parameters in Critically-Ill Patients.

Sanaie S, Ebrahimi-Mameghani M, Mahmoodpoor A, Shadvar K, Golzari SE.

J Cardiovasc Thorac Res. 2013;5(2):67-70. doi: 10.5681/jcvtr.2013.014. Epub 2013 Jun 27.

5.
6.

Cost-effectiveness of health risk reduction after lifestyle education in the small workplace.

Allen JC, Lewis JB, Tagliaferro AR.

Prev Chronic Dis. 2012;9:E96. Epub 2012 May 10.

7.

Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.

Roher AE, Garami Z, Tyas SL, Maarouf CL, Kokjohn TA, Belohlavek M, Vedders LJ, Connor D, Sabbagh MN, Beach TG, Emmerling MR.

Alzheimers Dement. 2011 Jul;7(4):445-55. doi: 10.1016/j.jalz.2010.09.002. Epub 2011 Mar 9.

8.

Fenofibrate and metabolic syndrome.

Kraja AT, Province MA, Straka RJ, Ordovas JM, Borecki IB, Arnett DK.

Endocr Metab Immune Disord Drug Targets. 2010 Jun;10(2):138-48. Review.

9.

The prince and the pauper. A tale of anticancer targeted agents.

Dueñas-González A, García-López P, Herrera LA, Medina-Franco JL, González-Fierro A, Candelaria M.

Mol Cancer. 2008 Oct 23;7:82. doi: 10.1186/1476-4598-7-82. Review.

10.

CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Kim E, Tolhurst AT, Qin LY, Chen XY, Febbraio M, Cho S.

J Neurosci. 2008 Apr 30;28(18):4661-70. doi: 10.1523/JNEUROSCI.0982-08.2008.

11.

Rosuvastatin: an independent analysis of risks and benefits.

Zipes DP, Zvaifler NJ, Glassock RJ, Gilman S, Muñoz A, Gogolak V, Gordis L, Dedon PC, Guengerich FP, Wasserman SI, Witztum JL, Wogan GN.

MedGenMed. 2006 Jun 14;8(2):73. Review.

12.

Supplemental Content

Support Center